Ad is loading...
AEPCX
Price
$54.55
Change
+$0.10 (+0.18%)
Updated
Nov 21 closing price
BGCJX
Price
$14.94
Change
+$0.04 (+0.27%)
Updated
Nov 21 closing price
Ad is loading...

AEPCX vs BGCJX

Header iconAEPCX vs BGCJX Comparison
Open Charts AEPCX vs BGCJXBanner chart's image
American Funds Europacific Growth C
Price$54.55
Change+$0.10 (+0.18%)
VolumeN/A
CapitalizationN/A
Baillie Gifford EAFE Plus All Cap 3
Price$14.94
Change+$0.04 (+0.27%)
VolumeN/A
CapitalizationN/A
AEPCX vs BGCJX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. BGCJX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and BGCJX is a Buy.

FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 129B vs. BGCJX (300M). AEPCX pays higher dividends than BGCJX: AEPCX (0.81) vs BGCJX (0.00). AEPCX was incepted earlier than BGCJX: AEPCX (24 years) vs BGCJX (4 years). AEPCX is a more actively managed with annual turnover of: 34.00 vs. BGCJX (16.00). AEPCX has a lower initial minimum investment than BGCJX: AEPCX (250) vs BGCJX (100000000). BGCJX annual gain was more profitable for investors over the last year : 7.66 vs. AEPCX (6.83).
AEPCXBGCJXAEPCX / BGCJX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years4 years-
Gain YTD3.7011.545240%
Front LoadN/AN/A-
Min. Initial Investment2501000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets129B300M43,000%
Annual Yield % from dividends0.810.00-
Returns for 1 year6.837.6689%
Returns for 3 years-16.37-31.5152%
Returns for 5 years5.05N/A-
Returns for 10 years16.49N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRC59.581.42
+2.44%
California Resources Corp
PDS66.130.99
+1.52%
Precision Drilling Corp
CDW178.172.18
+1.24%
CDW Corp
SSBK36.830.36
+0.99%
Southern States Bancshares
BIAF1.24-0.04
-2.76%
bioAffinity Technologies